Cargando…

RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas

It is unclear how loss-of-function germline mutations in the widely-expressed co-chaperone AIP, result in young-onset growth hormone secreting pituitary tumours. The RET receptor, uniquely co-expressed in somatotrophs with PIT1, induces apoptosis when unliganded, while RET supports cell survival whe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Rendueles, Angela R., Chenlo, Miguel, Oroz-Gonjar, Fernando, Solomou, Antonia, Mistry, Anisha, Barry, Sayka, Gaston-Massuet, Carles, Garcia-Lavandeira, Montserrat, Perez-Romero, Sihara, Suarez-Fariña, Maria, Pradilla-Dieste, Alberto, Dieguez, Carlos, Mehlen, Patrick, Korbonits, Márta, Alvarez, Clara V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585666/ https://www.ncbi.nlm.nih.gov/pubmed/34588620 http://dx.doi.org/10.1038/s41388-021-02009-8

Ejemplares similares

Correction: RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas
por: Garcia-Rendueles, Angela R., et al.
Publicado: (2023)

GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells
por: Pradilla Dieste, Alberto, et al.
Publicado: (2020)

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors
por: Barry, Sayka, et al.
Publicado: (2019)

Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2018)

Unilateral hydrocephalus from a gangliocytoma-somatotrophinoma: first reported case
por: Ryder, Simon, et al.
Publicado: (2021)

SAT-LB056 Is AIP a Tumor Suppressor or an Oncogene? AIP as a Novel Regulator of the Oncogene BCL6 in Diffuse Large B Cell Lymphoma
por: BARRY, SAYKA, et al.
Publicado: (2019)

Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly
por: Chenlo, Miguel, et al.
Publicado: (2019)

Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
por: Dénes, Judit, et al.
Publicado: (2015)

AIP variant causing familial prolactinoma
por: Carty, David M., et al.
Publicado: (2020)

Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family
por: Marques, Pedro, et al.
Publicado: (2018)

Novel AIP mutation in exon 6 causing acromegaly in a German family
por: Detomas, M., et al.
Publicado: (2023)

Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition
por: Morgan, Rhodri M. L., et al.
Publicado: (2012)

In vivo bioassay to test the pathogenicity of missense human AIP variants
por: Aflorei, Elena Daniela, et al.
Publicado: (2018)

THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function
por: Wang, Xian, et al.
Publicado: (2023)

Risk category system to identify pituitary adenoma patients with AIP mutations
por: Caimari, Francisca, et al.
Publicado: (2018)

SAT-462 AIP Mutation-Positive Patients with Somatotropinomas End up Taller and Requiring Radiotherapy More Often Compared to AIP Mutation-Negative Patients: Data from 784 Familial and Young-Onset Cases
por: Marques, Pedro, et al.
Publicado: (2019)

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes
por: Endo, Toyoshi, et al.
Publicado: (2013)

Unusual AIP mutation and phenocopy in the family of a young patient with acromegalic gigantism
por: Imran, Syed Ali, et al.
Publicado: (2018)

Increased Population Risk of AIP‐Related Acromegaly and Gigantism in Ireland
por: Radian, Serban, et al.
Publicado: (2016)

Circulating aryl hydrocarbon receptor-interacting protein (AIP) is independent of GH secretion
por: Stojanovic, Marko, et al.
Publicado: (2019)

AIP Annual Meeting
por: Abashian, Alexander
Publicado: (1984)

AIP Annual Meeting
por: Margolis, Bernard, et al.
Publicado: (1980)

AIP Annual Meeting
por: Caswell, William E, et al.
Publicado: (1983)

AIP Annual Meeting
por: Heusch, Clemens A, et al.
Publicado: (1982)

AIP Annual Meeting
por: Carlson, Carl E
Publicado: (1975)

AIP Congress 2006
Publicado: (2006)

AIP mutations in Brazilian patients with sporadic pituitary adenomas: a single-center evaluation
por: Araujo, Paula Bruna, et al.
Publicado: (2017)

AIP or ARDS? Not just semantics
por: Singh, Navneet
Publicado: (2006)

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
por: Daly, Adrian F, et al.
Publicado: (2019)

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors
por: Marques, Pedro, et al.
Publicado: (2020)

Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child
por: Dutta, Pinaki, et al.
Publicado: (2019)

Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2015)

Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2016)

An unusual case of an ACTH-secreting macroadenoma with a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene
por: Dinesen, Pia T, et al.
Publicado: (2015)

Characterization of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutations in Familial Isolated Pituitary Adenoma Families
por: Igreja, Susana, et al.
Publicado: (2010)

The AIP Model of EMDR Therapy and Pathogenic Memories
por: Hase, Michael, et al.
Publicado: (2017)

Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5
por: Edwards, Thomas L., et al.
Publicado: (2009)

Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5
por: Edwards, T. L., et al.
Publicado: (2009)

AIP56: A Novel Bacterial Apoptogenic Toxin
por: Silva, Manuel T., et al.
Publicado: (2010)

An analysis of six cases of acute intermittent porphyria (AIP)
por: Ghosh, Soumitra, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_13cb54bkjp2mkq78kg2i10lvfd